Advances in antithrombotic agents

Cardiovascular and Hematological Agents in Medicinal Chemistry

Volumn 5, Issue 3, 2007, Pages 175-185

  Chakrabarti, Ranjan ^a   Kumar Das, Saibal ^a  

^a DR REDDY'S LABORATORIES LTD   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ALTEPLASE; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BLOOD CLOTTING FACTOR 10A INHIBITOR; CLOPIDOGREL; DALTEPARIN; DANAPAROID; ENOXAPARIN; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; FONDAPARINUX; HEPARIN; HIRULOG; LOW MOLECULAR WEIGHT HEPARIN; LY 517717; NADROPARIN; PARNAPARIN; PHYTOMENADIONE; PICLODIN; PLACEBO; PLASMINOGEN ACTIVATOR; PROTAMINE SULFATE; REVIPARIN; RIVAROXABAN; THROMBIN INHIBITOR; TICLOPIDINE; TINZAPARIN; TIROFIBAN; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG; UNINDEXED DRUG; UROKINASE; WARFARIN; XANTIDAR;

AGRANULOCYTOSIS; ANTICOAGULATION; ANTIINFLAMMATORY ACTIVITY; BLEEDING; BLEEDING TENDENCY; BLOOD DYSCRASIA; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTINUOUS INFUSION; DEEP VEIN THROMBOSIS; DIARRHEA; DRUG ABSORPTION; DRUG DOSE ESCALATION; DRUG DOSE TITRATION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG PROTEIN BINDING; DRUG STRUCTURE; DRUG TARGETING; DRUG WITHDRAWAL; FIBRINOLYSIS; FOOD; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; HEART INFARCTION; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; LOW DRUG DOSE; MORBIDITY; MORTALITY; NEUTROPENIA; NONHUMAN; OSTEOPENIA; OSTEOPOROSIS; REGULATORY MECHANISM; RESTENOSIS; REVIEW; RISK ASSESSMENT; SIDE EFFECT; STRUCTURE ACTIVITY RELATION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTOPENIA; THROMBOEMBOLISM; THROMBOGENESIS; THROMBOSIS; THROMBOTIC THROMBOCYTOPENIC PURPURA; VASCULAR DISEASE; VENOUS THROMBOEMBOLISM;

ANTICOAGULANTS; BLOOD COAGULATION; CLINICAL TRIALS; DRUG DESIGN; FIBRINOLYTIC AGENTS; HUMANS; PLATELET AGGREGATION INHIBITORS; THROMBOSIS;

EID: 34547515089     PISSN: 18715257     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152507781058717     Document Type: Review

References (58)

1. Cairns, JA.; Théroux, P.; Lewis, H.D., Jr.; Ezekowitz, M.; Meade, T.W. Chest, 2001, 119 (Suppl. 1), 228S.
2. Weitz, J.I.; Crowther, M.A. Am. J. Cardiovas. Drugs, 2003, 3, 201.
3. Kwaan, H.C.; Samama, M.M. Exp. Rev. Cardiovasc. Ther., 2004, 2, 511.
4. Chang, P. IDrugs, 2004, 7, 50.
5. Jneid, H.; Bhatt, D.L. Exp. Opin. Emerg. Drugs, 2003, 8, 349.
6. Goto, S. Curr. Vasc. Pharmacol., 2004, 2, 23.
7. Lijnen, H.R.; Collen, D. Thromb. Haemostasis, 1995, 74, 387.
8. Freedman, J. In Thrombosis and hemorrhage; Loscalzo, J. (Ed.), Blackwell Scientific Publications: Boston, MA, USA 1994, pp. 1155.
9. Ruef J; Katus, H.A. Exp. Opin. Investig. Drugs, 2003, 12, 781.
10. McLean, M.-L.; Adelman, S.J. Exp. Opin. Invest. Drugs, 1998, 7, 687.
11. Hirsh, J.; Warkentin, T.E.; Shaughnessy, S.G.; Anand, S.S.; Halperin, J.L.; Raschke, R.; Granger, C.; Ohman, E.M.; Dalen, J.E. Chest, 2001, 119 (Suppl. 1), S64.
12. Hirsh, J.; Levine, M. Blood, 1992, 79, 1.
13. Weitz, J. N. Engl. J. Med., 1997, 337, 688.
14. Young, E.; Prins, M.; Levine, M.; Hirsh, J. Thromb. Haemost., 1992, 67, 639.
15. Boneu, B.; Necciari, J.; Cariou, R.; Sie, P.; GAbaig, A.M.; Kieffer, G.; Dickinson, J.; Lamond, G.; Moelker, H.; Mant, T. Thromb. Haemost., 1995, 74, 1468.
16. Liem, T.K. Hemostasis and Thrombosis: In Vascular Surgery: A Comprehensive Review; 6 ed. W. S. Moore (Ed.), W. B. Saunders: Philadelphia, USA 2002, 71.
17. Quinn, M.J.; Fitzgerald, D.J. Circulation, 1999, 100, 1667.
18. Saltiel, E.; Ward, A. Drugs, 1987, 34, 222.
19. Mousa, S.A.; Fareed, J. IBC's 11th. Exp. Opin. Invest. Drugs, 2001, 10, 157.
20. Steinhubl, S.R.; Kottke-Marchant, K.; Moliterno, D.J.; Rosenthal, M.L.; Godfrey, N.K.; Coller, B.S.; Topol, E.J.; Lincoff, A.M. Circulation, 1999, 100, 1977.
21. Mascelli, M.A.; Lance, E.T.; Damaraju, L.; Wagner, C.L.; Weisman, H.F.; Jordan, R.E. Circulation, 1996, 97, 1680.
22. Wagner, C.L.; Mascelli, MA.; Neblock, D.S.; Weisman, H.F.; Coller, B.S.; Jordan, R.E. Blood, 1996, 88, 907.
23. Faulds, D.; Sorkin, E.M. Drugs, 1994, 48, 583.
24. The EPIC Investigation. N. Engl. J. Med., 1994, 330, 956.
25. Tulsyan, N.; Ouriel, K.; Kashyap, V. Exp. Opin. Emerg. Drugs, 2006, 11, 75.
26. White, W.F.; Barlow, G.H.; Mozen, M.M. Biochemistry, 1966, 5, 2160.
27. Stroughton, J.; Ouriel, K.; Shortell, C.K.; Cho, J.S.; Marder, V.J. J. Vasc. Surg., 1994, 19, 298.
28. Teitel, J.M.; Rosenberg, R.D. J. Clin. Invest., 1983, 71, 1383.
29. Miletich, J.P.; Jackson, C.M.; Majerus, P.W. J. Biochem., 1978, 153, 6908.
30. Perzborn, E.; Strassburger, J.; Wilmen, A.; Pohlmann, J.; Roehrig, S.; Schlemmer, K.-H.; Straub, A. J. Thromb. Haemost., 2005, 3, 514.
31. Eriksson, B.I.; Borris, L.; Dahl, O.E.; Haas, S.; Huisman, M.V.; Kakkar, A.K.; Misselwitz, F.; Kaelebo, P. J. Thromb. Haemost., 2006, 4, 121.
32. Turpie, A.G.G.; Fisher, W.D.; Bauer, K.A.; Kwong, L.M.; Irwin, M.W.; Kalebo, P.; Misselwitz, F.; Gent, M. J. Thomb. Haemost., 2005, 3, 2479.
33. Kubitza, D.; Haas, S. Exp. Opin. Invest. Drugs, 2006, 15, 843.
34. Paccaly. A.; Ozoux, M.-L.; Chu, V.; Simcox, K.; Marks, V.; Freyburger, G.; Sibille, M.; Shukla, U. Thromb. Haemost., 2005, 94, 1156.
35. Hinder, M.; Paccaly, A.; Frick, A.; Shukla, U.; Simcox, K.; Miller, B.; Gebauer, A. Thromb. Haemost., 2005, 93, 794.
36. Choay, J.; Petitou, M.; Lormeau, J.C.; Sinay, P.; Casu, B.; Gatti, G. Biochem. Biophys. Acta, 1983, 116, 492.
37. Sinay, P.; Jaquinet, J.-C.; Petitou, M.; Duchaussoy, P.; Lederman, I.; Choay, J.; Torri, G. Carbohydr. Res., 1984, 132, C5.
38. Petitou, M.; Duchaussoy, P.; Lederman, I.; Choay, J.; Sinay, P.; Jacquinet, J.-C.; Torri, G. Carbohydr. Res., 1986, 147, 221.
39. Walenga, J.M.; Petitou, M.; Lormeau, J.C.; Samama, M.; Fareed, J.; Choay, J. Thromb. Res., 1987, 46, 187.
40. Walenga, J.M.; Bara, L.; Petitou, M.; Samama, M.; Fareed, J.; Choay, J. Thromb. Res., 1988, 51, 23.
41. Hobbelen, P.M.J.; Van Dinther, T.G.; Vogel, G.M.T.; Van Boeckel, C.A.A.; Moelker, H.C.T.; Meuleman, D.G. Thromb. Haemos., 1990, 63, 265.
42. Broze, G.R., Jr. Blood Coag. Fibrinol., 1995, 6(Suppl. 1), S7.
43. Broze, G.R., Jr. Semin. Hematol., 1992, 29, 159.
44. Kaiser, B.; Hoppensteadt, D.H.; Farced, J. Exp. Opin. Invest. Drugs, 1998, 7, 1121.
45. Mosesson, M.W. Semin. Hematol., 1992, 29, 177.
46. Fiddler, G.I.; Lumley, P. Circulation, 1990, 21, 1269.
47. Anderluh, M.; Dolenc, M.S. Curr. Med. Chem., 2002, 9, 1229.
48. Sambrano, G.R.; Weiss, E.J.; Zheng, Y.W.; Huang, W.; Coughlin, S.R. Nature, 2001, 413, 74.
49. Coller, B.S.; Scudder, L.E.; Beer, J.; Marmur, J.D. Ann. N.Y. Acad. Sci., 1991, 614, 193.
50. The PURSUIT trial investigators. N. Engl. J. Med., 1998, 339, 436.
51. Platelet receptor inhibition in ischemic syndrome management in patients limited by unstable signs and symptoms (prism-plus) study investigators. N. Engl. J. Med., 1998, 338, 1488.
52. Platelet receptor inhibition in ischemic syndrome management (prism) study investigators. N. Engl. J. Med., 1998, 338, 1498.
53. Chew, D.P.; Bhatt, D.L.; Sapp, S.; Topol, E.J. Circulation, 2001, 103, 201.
54. Ansell, J.; Bergqvist, D. Drugs, 2004, 64(Suppl. 1), 1.
55. Dager, W.E.; Andersen, J.; Nutescu, E. Ann. Pharmacother., 2006, 40, 1558.
56. Downing, L.J.; Streiter, R.M.; Kadell, A.M.; Wilke, CA.; Greenfield, L.J.; Wakefield, T.W. J. Vasc. Surg., 1998, 28, 848.
57. Pacini, S.; Gulisano, M.; Vannucchi, S.; Ruggiero, M. Biochem. Biophys. Res. Comm., 2002, 290, 820.
58. Wang, A.; Templeton, D.M. Kidney Int., 1996, 49, 437.